Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuderer

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bondGeoffrey S Ginsburg, Nicole M Kuderer
Drugs|December 14, 2002
Filgrastim in patients with neutropenia: potential effects on quality of lifeGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
A primer in prognostic and predictive models: development and validation of neutropenia risk modelsGary H Lyman, Nicole M Kuderer
Thrombosis Research|May 28, 2014
Guidelines for treatment and prevention of venous thromboembolism among patients with cancerNicole M Kuderer, Gary H Lyman
Brain and Cognition|January 21, 2026
Sex and handedness differences in Big Five personality traits and depression: Investigating the role of cerebral lateralizationSonja Kuderer, Christoph Rotter, Sylvia Kirchengast
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
Current Opinion in Oncology|August 14, 1998
Economic impact of granulopoiesis stimulating agents on the management of febrile neutropeniaG H Lyman, N M Kuderer, L Balducci
Cancer Investigation|October 18, 2022
Risk Model Development and Validation in Clinical Oncology: Lessons LearnedGary H Lyman, Pavlos Msaouel, Nicole M Kuderer
The American Journal of Medicine|March 21, 2002
Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysisGary H Lyman, Nicole M Kuderer, Benjamin Djulbegovic
Current Opinion in Hematology|April 16, 2002
Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patientsGary H Lyman, Nicole M Kuderer, Lodovico Balducci
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bondGeoffrey S Ginsburg, Nicole M Kuderer
Drugs|December 14, 2002
Filgrastim in patients with neutropenia: potential effects on quality of lifeGary H Lyman, Nicole M Kuderer
Supportive Cancer Therapy|July 17, 2008
A primer in prognostic and predictive models: development and validation of neutropenia risk modelsGary H Lyman, Nicole M Kuderer
Thrombosis Research|May 28, 2014
Guidelines for treatment and prevention of venous thromboembolism among patients with cancerNicole M Kuderer, Gary H Lyman
Brain and Cognition|January 21, 2026
Sex and handedness differences in Big Five personality traits and depression: Investigating the role of cerebral lateralizationSonja Kuderer, Christoph Rotter, Sylvia Kirchengast
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
Current Opinion in Oncology|August 14, 1998
Economic impact of granulopoiesis stimulating agents on the management of febrile neutropeniaG H Lyman, N M Kuderer, L Balducci
Cancer Investigation|October 18, 2022
Risk Model Development and Validation in Clinical Oncology: Lessons LearnedGary H Lyman, Pavlos Msaouel, Nicole M Kuderer
The American Journal of Medicine|March 21, 2002
Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysisGary H Lyman, Nicole M Kuderer, Benjamin Djulbegovic
Current Opinion in Hematology|April 16, 2002
Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patientsGary H Lyman, Nicole M Kuderer, Lodovico Balducci
Pageof 13